Brings 20+ years in healthcare, previously at Thermo Fisher Scientific. Expected to drive growth and execute long-term strategic initiatives. Henry Schein, a provider of healthcare products and ...
Hosted on MSN
Henry Schein outlines 2026 EPS growth target of 5%–8% and strategic initiatives amid leadership transition
Stanley Bergman, Executive Chairman & CEO, announced the transition of leadership to Fred Lowery, who will become CEO next week. Bergman stated, "Fred will officially join Henry Schein next week as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results